Skip to main content
Top
Published in: Archives of Virology 7/2018

01-07-2018 | Annotated Sequence Record

Complete genome sequence analysis of PS2, a novel T4-like bacteriophage that infects Serratia marcescens clinical isolates

Authors: Tieshan Teng, Gai Zhang, Xiangyu Fan, Zhenjiang Zhang, Lei Zhang, Dongdong Wu, Songjian Chen, Yanzhang Li, Jing Jin

Published in: Archives of Virology | Issue 7/2018

Login to get access

Abstract

In this study, we isolated and characterized a lytic phage, named vB_SmaM_PS2 (abbreviated as PS2), which can infect Serratia marcescens clinical isolates. Morphologically, phage PS2 can be classified within the Myoviridae family. The 167,276 bp double-stranded DNA genome of PS2 possesses 41.7% GC content. A total of 276 protein-coding genes and 4 tRNA genes were predicted in the PS2 genome. Of the 276 genes, 131 (47%) encoded T4-like genes, most of which are DNA replication and virion structural genes. Therefore, phage PS2 should be a new member of the T4-like Serratia phage.
Literature
1.
go back to reference Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, Li YH, Ma YY, Wang J, Liu F, Chen XD, Li GX, Wang XT, Wang ZQ, Zhao GQ (2012) Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 12:156CrossRefPubMedPubMedCentral Jin J, Li ZJ, Wang SW, Wang SM, Huang DH, Li YH, Ma YY, Wang J, Liu F, Chen XD, Li GX, Wang XT, Wang ZQ, Zhao GQ (2012) Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 12:156CrossRefPubMedPubMedCentral
2.
go back to reference Kutateladze M, Adamia R (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 28:591–595CrossRefPubMed Kutateladze M, Adamia R (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 28:591–595CrossRefPubMed
3.
go back to reference Lewis DA, Hawkey PM, Bennett PM (1983) Antibiotic resistance in Serratia marcescens. Br Med J 287:1651CrossRef Lewis DA, Hawkey PM, Bennett PM (1983) Antibiotic resistance in Serratia marcescens. Br Med J 287:1651CrossRef
4.
5.
go back to reference Maragakis LL, Winkler A, Tucker MG, Cosgrove SE, Ross T, Lawson E, Carroll KC, Perl TM (2008) Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 29:418–423CrossRefPubMed Maragakis LL, Winkler A, Tucker MG, Cosgrove SE, Ross T, Lawson E, Carroll KC, Perl TM (2008) Outbreak of multidrug-resistant Serratia marcescens infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 29:418–423CrossRefPubMed
7.
8.
go back to reference Sisirak M, Hukic M (2013) An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections. Acta Med Acad 42:25–31CrossRefPubMed Sisirak M, Hukic M (2013) An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections. Acta Med Acad 42:25–31CrossRefPubMed
Metadata
Title
Complete genome sequence analysis of PS2, a novel T4-like bacteriophage that infects Serratia marcescens clinical isolates
Authors
Tieshan Teng
Gai Zhang
Xiangyu Fan
Zhenjiang Zhang
Lei Zhang
Dongdong Wu
Songjian Chen
Yanzhang Li
Jing Jin
Publication date
01-07-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 7/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-3803-0

Other articles of this Issue 7/2018

Archives of Virology 7/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.